Dr. Jeffrey Carlyle Mcclean Ii is a Fort Sam Houston, Texas based neurologist who is specialized in Neurology. His current practice location is 3551 Roger Brooke Dr, Sammc Neurology, Fort Sam Houston. Patients can reach him at 210-373-2047 or can fax him at 210-916-3833. Dr. Jeffrey Carlyle Mcclean Ii is M.D. in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1790993475. Dr. Jeffrey Carlyle Mcclean Ii specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Dr. Jeffrey Carlyle Mcclean Ii speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Dr. Jeffrey Carlyle Mcclean Ii
Specialization:
Neurology
Gender:
Male
Credentials:
M.D.
Practice Address:
3551 Roger Brooke Dr, Sammc Neurology, Fort Sam Houston, Texas, 78234-4504
Phone:
210-373-2047
Fax:
210-916-3833
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1790993475
NPI Enumeration Date:
18 May, 2007
NPI Last Update On:
05 Jun, 2013
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Jeffrey Carlyle Mcclean Ii 3551 Roger Brooke Dr, Sammc Neurology Fort Sam Houston, Texas
Zip:
78234-4504
Phone Number:
210-373-2047
Fax Number:
210-916-3833
Patients can reach Dr. Jeffrey Carlyle Mcclean Ii at 3551 Roger Brooke Dr, Sammc Neurology, Fort Sam Houston, Texas or can call to book an appointment on 210-373-2047.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.